Others may have made fun of this ridiculous foray from the @nytimes into guidelines
But let’s quickly look at 2 related to the kidneys
(H/t @edclark75 for pointing out this which I would otherwise have ignored - and you should ignore)
1/

Link https://www.nytimes.com/interactive/2020/science/coronavirus-drugs-treatments.html

Go">https://www.nytimes.com/interacti... ahead and read it

No I am kidding. Don’t waste your time. It’s mostly idiotic

2/

For kidneys, here’s its recommendation for Cytosorb
‘Promising evidence’

How about strong evidence it doesn’t work instead? https://jamanetwork.com/journals/jama/fullarticle/2706139">https://jamanetwork.com/journals/... (different method, same principle)
3/

Why?
Removing a little bit of bad cytokines will not help
+
You will also remove good cytokines
+
Doing these procedures is not without harm
4/

And this total facepalm on RRT in COVID

Of course if there is AKI with a clinical indication, do RRT

But what’s this stuff about cytokine storm and viral invasion?

5/

Read this summary of literature from the #NephJC #COVIDAKI workgroup
http://www.nephjc.com/news/covidaki 

Direct">https://www.nephjc.com/news/covi... viral invasion is https://abs.twimg.com/emoji/v2/... draggable="false" alt="🤔" title="Denkendes Gesicht" aria-label="Emoji: Denkendes Gesicht">https://abs.twimg.com/emoji/v2/... draggable="false" alt="🤔" title="Denkendes Gesicht" aria-label="Emoji: Denkendes Gesicht">
ΑKI is mostly acute tubular injury, same as in patients from sepsis/SIRS even in non-COVID setting, best shown from @VelezNephHepato work cited within
6/

So after reviewing all the ways NYT doesn’t understand nephrology
Think about the Gell-Mann amnesia effect when you read anything else in the grey lady
7/7